Type 1 diabetes is a chronic condition in which the immune system destroys the insulin-producing cells in the pancreas, leaving the body unable to regulate blood sugar on its own. It accounts for roughly 5 to 10 percent of all diabetes cases and requires lifelong insulin replacement. Unlike type 2 diabetes, it is not caused by diet or lifestyle and cannot be reversed.
How Type 1 Diabetes Develops
Your pancreas contains clusters of cells called beta cells that produce insulin, the hormone responsible for moving sugar from your bloodstream into your cells for energy. In type 1 diabetes, the immune system mistakenly identifies these beta cells as a threat and gradually destroys them. By the time symptoms appear, a large majority of beta cells have already been lost.
This destruction doesn’t happen overnight. It can unfold over months or even years before blood sugar levels rise high enough to cause noticeable problems. People in the early stages typically have no symptoms at all. Once enough beta cells are gone, symptoms can appear suddenly, sometimes within just a few weeks.
Genetics play a significant role. Certain immune-system genes (specifically in a region called HLA) are strongly linked to risk. However, more than 10 percent of people diagnosed with type 1 diabetes don’t carry the highest-risk versions of these genes, meaning other genetic and environmental factors are also involved. Having a parent or sibling with type 1 raises your risk, but most people diagnosed have no family history of the disease.
Symptoms and Warning Signs
When type 1 diabetes does announce itself, the symptoms tend to be hard to ignore:
- Extreme thirst and frequent urination, because excess sugar in the blood pulls water from tissues and overwhelms the kidneys
- Unintentional weight loss, even with increased appetite, because the body starts breaking down fat and muscle for energy it can’t get from sugar
- Fatigue and weakness, since cells are starved of their primary fuel
- Blurred vision, caused by fluid shifts in the lenses of the eyes
- Nausea, vomiting, or fruity-smelling breath, which signal a dangerous buildup of acids called ketones
Type 1 is most commonly diagnosed in children, teenagers, and young adults, though it can appear at any age. In adults, it is sometimes initially mistaken for type 2 diabetes because of the assumption that type 1 is a childhood disease. Blood tests for specific autoantibodies, particularly one called anti-GAD, can confirm the immune-driven nature of the disease and distinguish it from type 2.
Diabetic Ketoacidosis: The Immediate Danger
Without insulin, the body cannot use sugar for energy and begins rapidly breaking down fat instead. This process floods the bloodstream with acidic byproducts called ketones. When ketone levels climb high enough, the blood becomes dangerously acidic, a condition called diabetic ketoacidosis (DKA). It is diagnosed when blood sugar exceeds 250 mg/dL, blood pH drops below 7.3, and ketone levels are significantly elevated.
DKA is a medical emergency. It can develop within hours and, if untreated, can lead to coma or death. For many people, a DKA episode is what leads to their initial type 1 diagnosis. Recognizing the symptoms listed above, especially nausea, vomiting, abdominal pain, and rapid breathing, can be lifesaving.
The Honeymoon Phase
Shortly after diagnosis and the start of insulin therapy, many people experience a period where blood sugar becomes surprisingly easy to manage. This is called the honeymoon phase. It happens because some functioning beta cells survive the initial immune attack, and once insulin treatment lowers blood sugar and reduces stress on the pancreas, those remaining cells can still contribute a small amount of insulin.
The honeymoon phase most commonly lasts a few months to a year, though in some cases it stretches to a few years. It is always temporary. The immune system continues its attack on the surviving beta cells, and eventually insulin needs will increase as the body’s own production drops to zero.
How Diagnosis Is Confirmed
A standard diabetes diagnosis relies on one or more of these blood test results:
- A1C of 6.5% or higher. This measures your average blood sugar over the past two to three months. Normal is below 5.7%.
- Fasting blood sugar of 126 mg/dL or higher. This is a single blood draw after at least eight hours without eating. Normal is below 100 mg/dL.
- Two-hour glucose tolerance test of 200 mg/dL or higher. This measures blood sugar after drinking a sugary solution. Normal is below 140 mg/dL.
These tests confirm diabetes but don’t specify which type. To confirm type 1, doctors test for autoantibodies, proteins that indicate the immune system is attacking the pancreas. The anti-GAD antibody test is the most reliable because these antibodies remain detectable long after diagnosis, unlike some other markers that fade over time. A second antibody test, anti-IA-2, is often run at the same time for added certainty.
Living With Type 1: Insulin and Blood Sugar Management
Everyone with type 1 diabetes needs insulin to survive. There is no pill, diet, or exercise regimen that can replace it. The goal of treatment is to mimic what a healthy pancreas does naturally: provide a steady background level of insulin throughout the day and deliver quick bursts to handle meals.
This is typically achieved with two categories of insulin. Long-acting insulin provides a baseline that lasts up to 24 hours (some formulations last up to 42 hours) and has no sharp peak, keeping blood sugar stable between meals and overnight. Rapid-acting insulin starts working within 5 to 15 minutes, peaks in one to three hours, and wears off in three to five hours, covering the sugar spike that follows eating. Most people take long-acting insulin once or twice a day and rapid-acting insulin before each meal.
Insulin can be delivered through daily injections using a pen or syringe, or through an insulin pump, a small device worn on the body that delivers insulin continuously through a tiny tube under the skin. The newest technology pairs an insulin pump with a continuous glucose monitor (CGM), a sensor worn on the skin that reads blood sugar levels every few minutes. These “closed-loop” systems automatically adjust insulin delivery based on real-time glucose readings. In clinical trials, closed-loop systems increased the amount of time users spent in a healthy blood sugar range by about 15 percentage points compared to using a pump and monitor separately.
Long-Term Complications
Over years and decades, elevated blood sugar damages small blood vessels throughout the body. The three most common targets are the eyes, kidneys, and nerves. Nearly all people with type 1 diabetes develop some degree of eye damage (diabetic retinopathy) after 20 years with the disease. Retinopathy is the leading cause of blindness in adults aged 20 to 74, though regular screening and modern treatments can catch and slow it before vision is lost.
Kidney damage follows a similar trajectory, with the filtering units of the kidneys gradually losing function over time. Nerve damage, most often felt as tingling, numbness, or pain in the feet and hands, affects a large proportion of people with long-standing diabetes. The risk of heart disease is also significantly higher.
The common thread in all these complications is blood sugar control. Keeping your A1C as close to normal as possible dramatically reduces the risk and severity of every one of these problems. This is why the day-to-day work of managing blood sugar, tedious as it can be, has such significant long-term payoffs. Modern tools like CGMs and closed-loop pumps have made tight control more achievable than at any point in the history of the disease.
Type 1 vs. Type 2: Key Differences
The two conditions share a name and some symptoms but differ in almost every other way. Type 1 is an autoimmune disease; the immune system destroys the pancreas’s ability to make insulin. Type 2 is a metabolic condition; the pancreas still makes insulin, but the body’s cells become resistant to it, and over time the pancreas may struggle to keep up with demand.
Type 2 is far more common, accounting for about 90 to 95 percent of all diabetes cases, and is strongly linked to weight, inactivity, and age. It often responds to lifestyle changes and oral medications, at least initially. Type 1 cannot be prevented, is not related to weight, and always requires insulin from the point of diagnosis. The onset of type 1 is typically abrupt and dramatic, while type 2 develops gradually over years, sometimes without obvious symptoms.

